Cleared Traditional

K933057 - MULTILITE ERBIUM:YAG SURGICAL LASER SYSTEM

K933057 is an FDA 510(k) clearance for MULTILITE ERBIUM:YAG SURGICAL LASER SYSTEM, manufactured by Continuum Electro-Optics, Inc.. The device is a Class 2 General & Plastic Surgery device with product code GEX cleared through the Traditional 510(k) pathway after a 497-day FDA review.

K933057 · Continuum Electro-Optics, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1994
Decision
497d
Days
Class 2
Risk

K933057 is an FDA 510(k) clearance for the MULTILITE ERBIUM:YAG SURGICAL LASER SYSTEM. Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.

Submitted by Continuum Electro-Optics, Inc. (Santa Clara, US). The FDA issued a Cleared decision on November 1, 1994 after a review of 497 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General & Plastic Surgery submissions.

View all Continuum Electro-Optics, Inc. devices

FDA 510(k) Submission Details - K933057

510(k) Number K933057 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 22, 1993
Decision Date November 01, 1994
Days to Decision 497 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
382d slower than avg
Panel avg: 115d · This submission: 497d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GEX Device Classification - Class 2, Special Controls

Product Code GEX Powered Laser Surgical Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEX Powered Laser Surgical Instrument

All 2094
Devices cleared under the same product code (GEX) and FDA review panel - the closest regulatory comparables to K933057.
MODEL 220-SC CURVED ENDOPHOTOCOAGULATOR LASER
K944627 · Mnlase, Inc. · Nov 1994
MODEL 220-SS LASER DELIVERY PROBE
K944628 · Mnlase, Inc. · Nov 1994
MODEL 230-SAC LASER DELIVERY PROBE
K944629 · Mnlase, Inc. · Nov 1994
OPTICAL FIBER FOR ENT APPLICATIONS
K944151 · Cardiogenes · Nov 1994
LASER DELIVERY PROBE
K944282 · Mnlase, Inc. · Nov 1994
CURVD ENDOPHOTOCOGULATOR LASER PROBE
K944472 · Mnlase, Inc. · Nov 1994